From recruitment to submission, hybrid and virtual clinical trials and the increased application of digital healthcare technologies present risks we may not have imagined . It’s essential to have plans in place to protect your emerging liabilities.
With virtual clinical trials and digital healthcare becoming the ‘new normal’ post COVID-19, its critical that we understand the areas of risk and what we need to do to protect our operations and participants. Join our panel of Insurance and Cyber risk Industry experts as they discuss the impact of cyber and liability risks to the Clinical Trials and Life Sciences sectors and find out what you must consider in order to actively respond to this pandemic as well as plan and prepare for the future.
Genevieve Matthews Senior Associate, Lockton Companies Australia
Mark Luckin Senior Associate, Cyber & Technology at Lockton Companies Australia
Will Clarke Underwriter at Newline Australia Pty Limited